Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

/PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today...

Related Keywords

Norway ,Oystein Soug ,Prnewswire Targovax ,Andreas Tinglum ,Damian Marron ,Renate Birkeli ,Erik Digman Wiklund ,Corporate Communications Norway ,Chief Executive Officer ,Chief Business Officer ,Chief Financial Officer ,Digman Wiklund ,Special Advisor ,Targovax ,